UY27719A1 - Un derivado de piridina ópticamente activo y un medicamento que lo contiene. - Google Patents
Un derivado de piridina ópticamente activo y un medicamento que lo contiene.Info
- Publication number
- UY27719A1 UY27719A1 UY27719A UY27719A UY27719A1 UY 27719 A1 UY27719 A1 UY 27719A1 UY 27719 A UY27719 A UY 27719A UY 27719 A UY27719 A UY 27719A UY 27719 A1 UY27719 A1 UY 27719A1
- Authority
- UY
- Uruguay
- Prior art keywords
- optically active
- product containing
- medicinal product
- pyridine derivative
- active pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Una ( - ) -(2-(ciclopropilmetoxi) -6-hidroxifenil)-((3S)-3-piperidinil)-1,4-dihidro-2H-pirido(2,3-d)(1,3)oxazin-2ona ópticamente activa de fórmula o una sal del mismo. El compuesto tiene una excelente actividad antiinfalmatoria y otra actividad biológica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002070655A JP2003277383A (ja) | 2002-03-14 | 2002-03-14 | 光学活性ピリジン誘導体およびそれを含む医薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27719A1 true UY27719A1 (es) | 2003-10-31 |
Family
ID=27800344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27719A UY27719A1 (es) | 2002-03-14 | 2003-03-12 | Un derivado de piridina ópticamente activo y un medicamento que lo contiene. |
Country Status (13)
Country | Link |
---|---|
US (2) | US7375103B2 (es) |
EP (1) | EP1487842B1 (es) |
JP (2) | JP2003277383A (es) |
AR (1) | AR038950A1 (es) |
AU (1) | AU2003215624A1 (es) |
CA (1) | CA2478942A1 (es) |
DE (1) | DE60312494T2 (es) |
ES (1) | ES2283795T3 (es) |
HN (1) | HN2003000098A (es) |
PE (1) | PE20040242A1 (es) |
TW (1) | TW200403247A (es) |
UY (1) | UY27719A1 (es) |
WO (1) | WO2003076447A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005036655A1 (de) * | 2005-08-04 | 2007-02-08 | Bayer Healthcare Ag | Behandlung von Tumoren mit IKK-ß Inhibitoren |
CA2646316C (en) | 2006-03-15 | 2016-05-24 | Theralogics, Inc. | Methods of treating muscular wasting diseases using nf-kb activation inhibitors |
WO2008044339A1 (fr) * | 2006-10-13 | 2008-04-17 | Aqumen Biopharmaceuticals K.K. | Agent thérapeutique/de prévention contenant un composé de statine, utilisé pour une maladie intraoculaire |
KR20130097813A (ko) | 2008-04-21 | 2013-09-03 | 오토노미, 인코포레이티드 | 귀 질환 및 병태를 치료하기 위한 귀 조제물 |
US11969501B2 (en) | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
UA122822C2 (uk) | 2013-04-08 | 2021-01-06 | Байєр Фарма Акцієнгезелльшафт | ЗАСТОСУВАННЯ ЗАМІЩЕНИХ 2,3-ДИГІДРОІМІДАЗО[1,2-c]ХІНАЗОЛІНІВ ДЛЯ ЛІКУВАННЯ ЛІМФОМ |
EP3288558B1 (en) | 2015-04-30 | 2022-05-11 | Bayer Pharma Aktiengesellschaft | Combinations of inhibitors of irak4 with inhibitors of btk |
CA3016364A1 (en) | 2016-03-03 | 2017-09-08 | Bayer Pharma Aktiengesellschaft | New 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs |
JP7033789B2 (ja) | 2016-06-29 | 2022-03-11 | オトノミー,インク. | トリグリセリド耳用製剤とその使用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4272338B2 (ja) | 2000-09-22 | 2009-06-03 | バイエル アクチェンゲゼルシャフト | ピリジン誘導体 |
-
2002
- 2002-03-14 JP JP2002070655A patent/JP2003277383A/ja active Pending
-
2003
- 2003-03-03 ES ES03743829T patent/ES2283795T3/es not_active Expired - Lifetime
- 2003-03-03 DE DE60312494T patent/DE60312494T2/de not_active Expired - Fee Related
- 2003-03-03 CA CA002478942A patent/CA2478942A1/en not_active Abandoned
- 2003-03-03 AU AU2003215624A patent/AU2003215624A1/en not_active Abandoned
- 2003-03-03 JP JP2003574663A patent/JP2005526074A/ja active Pending
- 2003-03-03 EP EP03743829A patent/EP1487842B1/en not_active Expired - Lifetime
- 2003-03-03 WO PCT/EP2003/002169 patent/WO2003076447A1/en active IP Right Grant
- 2003-03-03 US US10/508,107 patent/US7375103B2/en not_active Expired - Fee Related
- 2003-03-12 AR ARP030100859A patent/AR038950A1/es not_active Application Discontinuation
- 2003-03-12 UY UY27719A patent/UY27719A1/es not_active Application Discontinuation
- 2003-03-13 HN HN2003000098A patent/HN2003000098A/es unknown
- 2003-03-13 TW TW092105417A patent/TW200403247A/zh unknown
- 2003-03-13 PE PE2003000253A patent/PE20040242A1/es not_active Application Discontinuation
-
2008
- 2008-05-19 US US12/123,405 patent/US20090054424A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PE20040242A1 (es) | 2004-05-15 |
DE60312494D1 (de) | 2007-04-26 |
AU2003215624A1 (en) | 2003-09-22 |
US20090054424A1 (en) | 2009-02-26 |
EP1487842A1 (en) | 2004-12-22 |
WO2003076447A1 (en) | 2003-09-18 |
AR038950A1 (es) | 2005-02-02 |
ES2283795T3 (es) | 2007-11-01 |
CA2478942A1 (en) | 2003-09-18 |
DE60312494T2 (de) | 2007-11-29 |
US7375103B2 (en) | 2008-05-20 |
EP1487842B1 (en) | 2007-03-14 |
JP2005526074A (ja) | 2005-09-02 |
TW200403247A (en) | 2004-03-01 |
JP2003277383A (ja) | 2003-10-02 |
US20050215547A1 (en) | 2005-09-29 |
HN2003000098A (es) | 2003-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122052T1 (el) | Πολυκυκλικο παραγωγο καρβαμοϋλπυριδονης που εχει ανασταλτικη δραστηριοτητα ιντεγ(κ)ρασης [ενσωματασης] toy hiv | |
AR028706A1 (es) | Tiazina oxazolidinona | |
DE69829846D1 (de) | Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität | |
AR033423A1 (es) | Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos | |
UY26380A1 (es) | Inhibidores de fab i | |
BR0311672B1 (pt) | aparelho de proteção de agulha médica. | |
NO20052787D0 (no) | N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
BR0116217A (pt) | Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas | |
DE60334678D1 (de) | Antikörper enthaltende pharmazeutische lösungen | |
NO20053224D0 (no) | Patient controlled drug administration device. | |
CY1107181T1 (el) | Συνδυασμος ζιζανιοκτονων με ακυλιωμενες αμινοφαινυλοσουλφονυλουριες | |
DK1295600T3 (da) | Lægemiddel baseret på gestagener til dermal anvendelse indeholdende ascorbinsyre og/eller salte deraf | |
UY27719A1 (es) | Un derivado de piridina ópticamente activo y un medicamento que lo contiene. | |
NO996208D0 (no) | Nye 2-(iminometyl)amino- fenylderivater, fremstilling og blandinger derav, samt anvendelse som legemiddel | |
EP0976722A4 (en) | benzamidine | |
NO20052788L (no) | N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
NO20042497L (no) | 4,4-diflour-1,2,3,4-tetrahydro-5H-1-benzazepinderivater og salter av disse | |
CY1119402T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
AR030503A1 (es) | Antibioticos de cefalosporina y prodrogas de los mismos | |
IT1308678B1 (it) | Siringa per infusione di farmaci. | |
DOP2003000612A (es) | Un derivado de piridina opticamente activo y un medicamento que lo contiene | |
EE200200532A (et) | Intravenoosselt manustatava linesoliidi lahuse mahuti | |
NO20002321L (no) | Bifenylderivater som farmasøytiske midler | |
ATE491709T1 (de) | Pyrrolidinohydrochinazoline | |
CL2004001343A1 (es) | Compuesto derivado del ester de 3,3-dimetil-4,4,7-trioxo-4-tia-1-aza-biciclo [3.2.0]-heptano-2-carboxilico, composicion farmaceutica, inhibidores de beta lactama, utiles para tratar una infeccion bacteriana. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150427 |